ZA803483B - Muramyldipeptide derivatives - Google Patents

Muramyldipeptide derivatives

Info

Publication number
ZA803483B
ZA803483B ZA00803483A ZA803483A ZA803483B ZA 803483 B ZA803483 B ZA 803483B ZA 00803483 A ZA00803483 A ZA 00803483A ZA 803483 A ZA803483 A ZA 803483A ZA 803483 B ZA803483 B ZA 803483B
Authority
ZA
South Africa
Prior art keywords
group
carbon atoms
image
acyl
muramyldipeptide derivatives
Prior art date
Application number
ZA00803483A
Other languages
English (en)
Inventor
Hidemasa Ogawa
Ogawa Hidemasa
Osamu Nagase
Nagase Osamu
Shozo Kotani
Kotani Shozo
Tetsuo Shiba
Shiba Tetsuo
Yuichi Yamamura
Yamamura Yuichi
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of ZA803483B publication Critical patent/ZA803483B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA00803483A 1979-06-21 1980-06-11 Muramyldipeptide derivatives ZA803483B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7831779A JPS5618996A (en) 1979-06-21 1979-06-21 Muramyldipeptide derivative

Publications (1)

Publication Number Publication Date
ZA803483B true ZA803483B (en) 1981-06-24

Family

ID=13658554

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00803483A ZA803483B (en) 1979-06-21 1980-06-11 Muramyldipeptide derivatives

Country Status (11)

Country Link
US (1) US4317771A (xx)
EP (1) EP0021367B1 (xx)
JP (1) JPS5618996A (xx)
AT (1) ATE2958T1 (xx)
AU (1) AU534233B2 (xx)
CA (1) CA1183128A (xx)
DE (1) DE3062609D1 (xx)
ES (1) ES492664A0 (xx)
PH (1) PH15892A (xx)
SU (1) SU1190990A3 (xx)
ZA (1) ZA803483B (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2482959A2 (fr) * 1979-06-29 1981-11-27 Rhone Poulenc Ind Nouveaux tripeptides, leur preparation et les medicaments qui les contiennent
GR78246B (xx) * 1981-01-23 1984-09-26 Ciba Geigy Ag
US4522811A (en) * 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
JPS5920297A (ja) * 1982-07-27 1984-02-01 Dai Ichi Seiyaku Co Ltd ムラミルジペプチド誘導体
JPS59172497A (ja) * 1983-03-22 1984-09-29 Dai Ichi Seiyaku Co Ltd 新規ムラミルペプチド誘導体
FR2546756B1 (fr) * 1983-06-03 1985-11-29 Centre Nat Rech Scient Nouveaux derives immunostimulants, leur preparation et leur application comme medicament
US4474693A (en) * 1983-10-31 1984-10-02 E. R. Squibb & Sons, Inc. ACE inhibitors produced from Nocardia orientalis
JPS6157597A (ja) * 1984-08-29 1986-03-24 Toshiyuki Hamaoka ムラミルペプチド活性エステル誘導体
JPS6393724A (ja) * 1986-10-09 1988-04-25 Dai Ichi Seiyaku Co Ltd ムラミルジペプチド誘導体含有鎮痛消炎剤
US5416070A (en) * 1988-07-08 1995-05-16 Immunotherapeutics, Inc. Composition for macrophage activation
US4950645A (en) * 1988-07-08 1990-08-21 Immunotherapeutics, Inc. Composition for macrophage activation
GB9320820D0 (en) * 1993-10-08 1993-12-01 Biokine Tech Ltd Compounds for medicinal use
CN100522995C (zh) * 2003-10-22 2009-08-05 中国医学科学院药物研究所 胞壁酰-丙氨酰-d-异谷氨酰胺衍生物、制法和其药物组合物与用途
US9688718B2 (en) 2008-01-11 2017-06-27 Lawrence Livermore National Security, Llc Nanolipoprotein particles comprising hydrogenases and related products, methods and systems
US9303273B2 (en) 2008-05-09 2016-04-05 Lawrence Livermore National Security, Llc Nanolipoprotein particles comprising a natural rubber biosynthetic enzyme complex and related products, methods and systems
WO2009143280A2 (en) * 2008-05-22 2009-11-26 Lawrence Livermore National Security, Llc Nanolipoprotein particles and related compositions, methods and systems
RU2604718C2 (ru) 2010-05-27 2016-12-10 Шэньчжэнь Салубрис Фармасьютикалз Ко.,Лтд. Химический синтез и противоопухолевый и противометастатический эффекты конъюгата двойного действия
CN102219834A (zh) * 2011-04-14 2011-10-19 北京市丰硕维康技术开发有限责任公司 一种制备罗莫肽的方法
US9644038B2 (en) 2011-12-21 2017-05-09 The Regents Of The University Of California Apolipoprotein nanodiscs with telodendrimer
WO2016049061A1 (en) 2014-09-22 2016-03-31 Lawrence Livermore National Security, Llc Electrochemical flow-cell for hydrogen production and nicotinamide co-factor dependent target reduction, and related methods and systems
WO2016138286A1 (en) 2015-02-26 2016-09-01 Stc.Unm Irgm and precision autophagy controls for antimicrobial and inflammatory disease states and methods of detection of autophagy
US11279749B2 (en) 2015-09-11 2022-03-22 Lawrence Livermore National Security, Llc Synthetic apolipoproteins, and related compositions methods and systems for nanolipoprotein particles formation
US11207422B2 (en) 2017-05-02 2021-12-28 Lawrence Livermore National Security, Llc MOMP telonanoparticles, and related compositions, methods and systems
WO2022198101A1 (en) 2021-03-19 2022-09-22 Trained Therapeutix Discovery, Inc. Compounds for regulating trained immunity, and their methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH613709A5 (en) * 1975-12-10 1979-10-15 Ciba Geigy Ag Process for the preparation of glucosamine derivatives
FR2358159A1 (fr) * 1976-07-16 1978-02-10 Anvar Le diamide de l'acide 2-(2-acetamido-2-deoxy-3 - o-d-glucopyranosyl) - d-propionyl-l-alanyl-d-glutamique et medicaments le contenant
EP0003833B2 (de) * 1978-02-24 1990-12-19 Ciba-Geigy Ag Antigenderivate, Verfahren zu deren Herstellung, diese enthaltende pharmazeutische Präparate
FR2442241A2 (fr) * 1978-03-20 1980-06-20 Anvar Nouveaux composes esters de muramyl-peptide, leur preparation et les compositions pharmaceutiques les contenant, notamment sous forme de liposomes
FR2428050A1 (fr) * 1978-06-05 1980-01-04 Anvar Oligomeres de composes du type muramyl-peptide et medicaments les contenant
US4256735A (en) * 1979-01-29 1981-03-17 Merck & Co., Inc. Immunologically active dipeptidyl saccharides and methods of preparation

Also Published As

Publication number Publication date
SU1190990A3 (ru) 1985-11-07
ES8200645A1 (es) 1981-11-16
ES492664A0 (es) 1981-11-16
CA1183128A (en) 1985-02-26
AU534233B2 (en) 1984-01-12
JPS6227079B2 (xx) 1987-06-12
EP0021367A1 (en) 1981-01-07
EP0021367B1 (en) 1983-04-06
DE3062609D1 (en) 1983-05-11
AU5910180A (en) 1981-01-08
JPS5618996A (en) 1981-02-23
ATE2958T1 (de) 1983-04-15
US4317771A (en) 1982-03-02
PH15892A (en) 1983-04-14

Similar Documents

Publication Publication Date Title
AU534233B2 (en) Muramyldipeptide derivatives
IE801251L (en) Inhibitors of mammalian collagenase
AU515774B2 (en) Benzopyran derivatives
IE801342L (en) Peptides
NL300164I2 (nl) Gaba- en L-glutaminezuuranaloga voor behandeling tegen convulsies.
DE3270583D1 (en) Inhibitors of mammalian collagenase
SE9100342D0 (sv) Novel steroid esters
GR3002502T3 (en) Process for the synthesis of n-dialkylaminoalkyl (meth)acryl amide
SE8604950D0 (sv) Dementia-improving and therapeutic agents
ES2076623T3 (es) 3,4-dihidro-naftalinas sustituidas, su procedimiento de preparacion y medicamentos que las contienen.
RS50423B (sr) Novi derivati oktahidro-6,10-diokso-6h-piridazino(1,2-a) (1,2) diazepin-1-karboksilne kiseline, njihov postupak dobijanja i njihova primena za dobijanje farmaceutski aktivnih jedinjenja
GEP19970937B (en) Method of producing derivatives of muramyldipeptide
SE8206981D0 (sv) N-(vinblastinoyl-23) derivatives of amino acids, their preparation and therapeutical application
EP0331756A4 (en) Agents for prophylaxis and treatment of thrombopenia
ES453997A1 (es) Procedimiento para la preparacion de acetatos de eteraminas secundarias.
DE69633281D1 (de) Etherderivate von pseudopterosin
NL7505473A (nl) Werkwijze voor het bereiden van pyroglutamylver- bindingen met antidepressieve werking.
ES465567A1 (es) Procedimiento para la preparacion de disulfuro de 2-amino- ciclopent-1-en-1tiocarbonilo
ES465568A1 (es) Procedimiento para la preparacion de acidos 2-amino-ciclo- pent-1-en-1-carboxilicos en n
ES472090A2 (es) Mejoras introducidas en el objeto de la patente principal n.451407 por:procedimiento para preparar derivados de amidoxi-ma